Performance analysis of Aclaris Therapeutics (ACRS)
Annual Return
Over the past 3 years, ACRS has had an average annual return of -19.40%, underperforming the benchmark SPY, which returned +19.31% annual.
Over the past 5 years, ACRS has had an average annual return of -18.64%, underperforming the benchmark SPY, which returned +12.55% annual.
Over the past 10 years, ACRS has had an average annual return of -12.40%, underperforming the benchmark SPY, which returned +14.95% annual.
Since Oct 7, 2015, ACRS has had an average annual return of -6.15%, underperforming the benchmark SPY, which returned +14.82% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +85.06% | +21.39% | +136.21% | -93.33% | +8.32% | +124.73% | +242.40% | -74.43% | -70.03% | -9.14% | +0.74% | +143.80% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +16.59% | -18.23% | +30.69% | +15.73% | +4.84% | +16.25% | +5.31% | +85.06% | |||||
| 2025 | -0% | -19.74% | -23.10% | -9.82% | +5.76% | -2.73% | +7.78% | +26.14% | -1.60% | +32.69% | +12.28% | +6.36% | +21.39% |
| 2024 | +10.53% | +2.57% | +4.18% | -2.41% | -14.89% | +6.76% | +21.91% | -11.95% | -2.53% | +57.35% | +124.85% | -39.07% | +136.21% |
| 2023 | +7.30% | -26.27% | -35.07% | +9.89% | -6.07% | +24.19% | -4.83% | -24.22% | -8.42% | -27.29% | -82.43% | +19.95% | -93.33% |
| 2022 | -24.90% | +36.45% | +15.71% | -28.54% | +3.82% | +9.14% | +10.39% | +3.24% | -1.07% | -0.82% | -2.50% | +3.48% | +8.32% |
| 2021 | +220.72% | +7.38% | +13.10% | -5.35% | -6.75% | -21.05% | -14.98% | +8.58% | +11.04% | -3.62% | -26.22% | +13.59% | +124.73% |
| 2020 | -34.39% | -8.02% | -8.82% | +27.95% | +5.98% | +14.89% | +32.74% | +14.39% | +4.49% | +49.40% | -13.01% | +93.68% | +242.40% |
| 2019 | -5.68% | -7.04% | -7.55% | +5.17% | -25.71% | -53.20% | -41.57% | -21.07% | +6.89% | +62.13% | -6.31% | +15.23% | -74.43% |
| 2018 | -10.30% | -9.86% | -12.14% | +1.31% | +1.81% | +10.51% | -14.17% | -7.12% | -8.79% | -18.11% | -21.62% | -20.70% | -70.03% |
| 2017 | -2.25% | +17.71% | -4.51% | -5.73% | -15.41% | +14.05% | +6.19% | -9.96% | -0.46% | -2.32% | -5.95% | +4.01% | -9.14% |
Drawdown analysis of Aclaris Therapeutics (ACRS)
The maximum drawdown for the ACRS was -98.04%, occurring on Nov 13, 2023. This drawdown has not yet recovered.
The current ACRS drawdown is -83.12%.
Since Oct 7, 2015 ACRS has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 2 times
- 30% or more: 2 times
- 20% or more: 2 times
- 10% or more: 5 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -98.04% | Apr 17, 2017 | 1656 | Nov 13, 2023 | Ongoing | Ongoing | Ongoing |
| -49.55% | Dec 22, 2015 | 63 | Mar 24, 2016 | 173 | Nov 29, 2016 | 236 |
| -19.68% | Dec 16, 2016 | 34 | Feb 7, 2017 | 13 | Feb 27, 2017 | 47 |
| -13.11% | Nov 23, 2015 | 7 | Dec 3, 2015 | 9 | Dec 16, 2015 | 16 |
| -12.04% | Mar 6, 2017 | 11 | Mar 21, 2017 | 18 | Apr 17, 2017 | 29 |
| -8.38% | Oct 12, 2015 | 1 | Oct 13, 2015 | 1 | Oct 14, 2015 | 2 |
| -8.03% | Oct 15, 2015 | 9 | Oct 28, 2015 | 9 | Nov 10, 2015 | 18 |
| -6.87% | Dec 6, 2016 | 5 | Dec 13, 2016 | 3 | Dec 16, 2016 | 8 |
| -3.96% | Feb 27, 2017 | 3 | Mar 2, 2017 | 1 | Mar 3, 2017 | 4 |
| -3.93% | Nov 10, 2015 | 1 | Nov 11, 2015 | 2 | Nov 13, 2015 | 3 |
| -3.75% | Nov 29, 2016 | 2 | Dec 1, 2016 | 2 | Dec 5, 2016 | 4 |
| -0.83% | Dec 17, 2015 | 1 | Dec 18, 2015 | 1 | Dec 21, 2015 | 2 |
| -0.25% | Nov 18, 2015 | 1 | Nov 19, 2015 | 1 | Nov 20, 2015 | 2 |